Grupo Ferrer to market Alexza Adasuve
Adasuve is an anti-agitation therapeutic which combines Alexza’s proprietary Staccato system with loxapine, an antipsychotic drug. The Staccato system is a hand-held, single-dose inhaler that delivers a drug
HAYA Therapeutics has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational therapy, HTX-001, to treat symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).